Home > Income Statement > EMCURE PHARMACEUTICALS

EMCURE PHARMACEUTICALS
Revenue

    Back to Income Statement
EMCURE PHARMACEUTICALS is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

EMCURE PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹7,896 Cr₹6,658 Cr₹5,986 Cr₹5,855 Cr₹6,056 Cr

What is the latest Revenue of EMCURE PHARMACEUTICALS ?

The latest Revenue ratio of EMCURE PHARMACEUTICALS is ₹7,896 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹7,896 Cr
Mar2024₹6,658 Cr
Mar2023₹5,986 Cr
Mar2022₹5,855 Cr
Mar2021₹6,056 Cr

How is Revenue of EMCURE PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹7,896 Cr
18.59
Mar2024 ₹6,658 Cr
11.23
Mar2023 ₹5,986 Cr
2.23
Mar2022 ₹5,855 Cr
-3.32
Mar2021 ₹6,056 Cr -

Compare Revenue of peers of EMCURE PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS ₹27,578.3 Cr 1.4% -0.7% 45.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


EMCURE PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
EMCURE PHARMACEUTICALS

1.4%

-0.7%

45.8%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses